Direct Answer
Clinical workflow software helps hospitals and clinics schedule staff, document care, coordinate tasks and route information between clinicians. Vendors sell subscriptions to health systems, often alongside electronic health records.
Industry Overview
Clinical Workflow Software sits within the health care sector. The first numbers to compare across companies here are annual recurring revenue, net revenue retention and customer count by health-system size. The outside forces that move them are listed under Primary Macro Drivers.
Key Industry Metrics
- Annual recurring revenue: Yearly value of active subscription contracts. Steady growth shows health systems adopting and renewing, but it does not capture one-time implementation fees or contract losses until they occur.
- Net revenue retention: Revenue kept and expanded from existing customers over a year, net of cancellations. A level above 100% means existing hospitals are buying more modules or seats; below that signals churn or downsizing.
- Customer count by health-system size: Number of customers split by hospital or system size. Large systems bring bigger contracts but longer sales cycles, so the mix shows how dependent growth is on a few large deployments.
- Implementation backlog: Contracted deployments not yet live, often the point where revenue begins. A large backlog suggests future revenue, but long delays can signal staffing limits or hospital integration problems.
- Gross margin: Share of revenue left after hosting, support and implementation staff. Services-heavy rollouts depress it early, and margins usually improve as more revenue becomes recurring software.
Primary Macro Drivers
- Clinician burnout and staffing shortages: Short-staffed hospitals buy tools that cut paperwork and coordinate tasks, which supports new subscriptions and expansion in existing health systems.
- Health system technology budgets: Software is paid for out of hospital operating and capital budgets, so tight budgets slow deals and lengthen implementation backlog.
- Interoperability rules: Rules that require systems to exchange data push hospitals to buy tools that can connect, which supports demand for vendors that can integrate easily.
- Integration with electronic health records: Tools that plug into the main record system are easier to deploy and keep, so strong integration helps retention and shortens implementation time.
Major Risks
- Long sales and deployment cycles: Hospitals take many months to buy and deploy, so revenue lags effort; watch implementation backlog and the time between signing and billing.
- Dominance of large electronic health record vendors: If the main record vendors add similar features, they can bundle them at little extra cost and squeeze independent vendors; watch net revenue retention and win rates.
- Hospital budget constraints: Health systems with thin margins delay or shrink software purchases, which slows new customer additions and expansions; watch annual recurring revenue growth.
- Security and privacy incidents: A breach exposes patient data, bringing legal cost, customer loss and tighter contract terms; watch incident disclosures in filings and changes in retention.
Industry Characteristics
| Characteristic | Profile |
|---|---|
| Cyclicality | Defensive |
| Capital Intensity | Low |
| Regulatory Intensity | Medium |
| Industry Maturity | Growth |
| Geographic Importance | U.S. |
Companies Associated with Clinical Workflow Software
The SEC's Standard Industrial Classification has no code that describes clinical workflow software as a group, so there is no complete list of its filers. The companies below come from Swoopr's SEC dataset and have operations in or next to the industry. Each is classified by the SEC under its own main business.
| Company | SEC classification | Revenue | Growth | Net margin | Year |
|---|---|---|---|---|---|
| Oracle Corp | Services-Prepackaged Software | $67.4 billion | 17.3% | 25.2% | FY 2026 |
| Veeva Systems Inc | Services-Prepackaged Software | $3.2 billion | 16.3% | 28.4% | FY 2026 |
| Teladoc Health, Inc. | Services-Offices & Clinics Of Doctors Of Medicine | $2.5 billion | -1.5% | -7.9% | FY 2025 |
| Doximity, Inc. | Services-Computer Programming Services | $645 million | 13.1% | 30.4% | FY 2026 |
Source: each company's own annual report as filed with the SEC (XBRL data), figures in U.S. dollars. Listing here describes a business relationship to the industry, not a recommendation. To find more companies, use the company directory and the health care hub.
Where to Go Next
The Clinical Workflow Software guide describes how the industry earns money, what to measure and what can go wrong. To see how it compares, read the neighbouring industries in the same sector, then apply the same checks to a specific company.
More in Health Care
- Health Care sector overview
- CNS Pharmaceuticals
- Clinical Trial Technology
- Contract Development & Manufacturing Organizations
- Clinical-Stage Biotechnology
- Contract Research Organizations
- Cell Therapy
- Dental Equipment
- Care Delivery
Put it to work
Frequently Asked Questions
What are the main KPIs for the Clinical Workflow Software industry?
Key performance indicators for the Clinical Workflow Software industry include: Annual recurring revenue, Net revenue retention, Customer count by health-system size, Implementation backlog, Gross margin. Which matter most depends on the company's model, so compare them across several companies rather than relying on one.
How cyclical is the Clinical Workflow Software industry?
The Clinical Workflow Software industry is generally defensive, meaning demand tends to remain relatively stable regardless of the economic cycle. Companies in this space can provide portfolio stability during recessions, though growth may lag in strong expansions.
What are the biggest risks in the Clinical Workflow Software industry?
The primary risks for Clinical Workflow Software companies include: Long sales and deployment cycles, Dominance of large electronic health record vendors, Hospital budget constraints, Security and privacy incidents. Investors should assess each company's exposure to these factors and its track record of navigating them.